Bedfont Scientific Ltd. has sold its U.K. subsidiary, NOxBOX Ltd, to Praxair Gases UK, Ltd., a subsidiary of Praxair, a Fortune 250 company with 2015 sales of $11 billion and one of the largest industrial gas companies worldwide. Financial terms of the transaction were not disclosed. Bedfont’s sale of NOxBOX Ltd includes the full NOxBOX range of critical care delivery and monitoring devices for inhaled nitric oxide therapy.
EC M&A acted as exclusive financial advisor to Bedfont on this transaction.
